24-Hour ambulatory blood pressure monitoring in patients with malignancies enrolled in phase I oncological studies

24-Hour ambulatory blood pressure monitoring in patients with malignancies enrolled in phase I oncological studies - ABPM in patients with malignancies

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32306

Enrollment

Registered

2008-08-21

Start date

2008-07-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer / hypertensie

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - enrolled in ongoing or future phase I studies of novel anti-cancer agents at the NKI-AVL - scheduled to be hospitalized for at least a 24 hours during the phase I trial

Exclusion criteria

Exclusion criteria: - currently associated with essential hypertension, cardiovascular disease or renal impairment - currently treated with drugs that are known to have an effect on the cardiovascular and/or the renovascular system

Design outcomes

Primary

Measure	Time frame
Mathematical models will be fitted to the 24-hour blood pressure data.	—

Countries

Netherlands

Outcome results